Novo Nordisk A/S Common Stock (NVO)

Investing Cash Flow

-kr 82.71B

TTM · Period ending: · DKK

NVO logo

NVO Investing Cash Flow

Latest reported-kr 82.71B DKK
NVO TTM Cash from Investing · DKK (-kr 2.01B → -kr 82.71B)
High-resolution chart · PNG

NVO investing cash flow history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Investing Cash Flow — Trailing twelve months (TTM) (DKK)
Period endingInvesting Cash Flow (DKK)
-82,713,000,000
-84,197,000,000
-79,158,000,000
-127,562,000,000
-133,041,000,000
-139,524,000,000
-128,895,000,000
-52,396,000,000
-44,735,000,000
-33,289,000,000
-43,892,000,000
-43,025,000,000
-34,743,000,000
-29,658,000,000
-24,918,000,000
-31,671,000,000
-31,345,000,000
-30,031,000,000
-31,605,000,000
-23,902,000,000
-25,330,000,000
-23,811,000,000
-22,436,000,000
-12,745,000,000
-9,123,000,000
-10,589,000,000
-11,509,000,000
-12,399,000,000
-12,822,000,000
-12,532,000,000
-12,080,000,000
-11,144,000,000
-10,271,000,000
-8,453,000,000
-6,571,000,000
-6,139,000,000
-6,825,000,000
-5,876,000,000
-6,790,000,000
-8,754,000,000
-9,379,000,000
-9,546,000,000
-6,098,000,000
-2,980,000,000
-712,000,000
-638,000,000
-2,064,000,000
-1,008,000,000
-1,973,000,000
-1,964,000,000
-2,773,000,000
-3,869,000,000
-3,646,000,000
-3,114,000,000
-4,070,000,000
-4,985,000,000
-3,811,000,000
-4,703,000,000
-3,459,000,000
-4,538,000,000
-4,801,000,000
-5,362,000,000
-5,579,000,000
-3,149,000,000
-3,081,000,000
-2,846,000,000
-3,046,000,000
-2,186,077,450
-1,856,291,000
-1,638,320,150
-1,385,442,800
-911,831,350
-1,054,345,750
-1,341,502,250
-1,518,858,000
-2,468,130,670
-2,694,516,450
-2,849,679,150
-2,520,167,600
-3,960,592,370
-4,290,125,840
-4,291,554,920
-4,904,496,440
-3,873,466,620
-3,601,020,930
-3,275,629,760
-2,014,026,270
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.